Basic Information
ID: ALA4343086
Type: Binding
Description: Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP
Format: BAO_0000219
Organism: Homo sapiens
Cell type: Sf9
Target: Platelet-derived growth factor receptor alpha(ALA2007)
Document: ALA4342414
Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4343086
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 560.68 | 5.86 | 5.86 |
| 490.66 | 4.20 | 4.20 |
| 464.62 | 3.67 | 3.67 |
| 465.60 | 3.70 | 3.70 |
| 565.77 | 5.69 | 5.69 |
| 463.57 | 4.77 | 4.77 |
| 506.66 | 3.17 | 3.17 |
| 458.57 | 3.95 | 3.95 |
| 454.58 | 1.94 | 1.94 |
| 457.59 | 4.55 | 4.55 |
| 529.69 | 3.43 | 3.43 |
| 464.62 | 3.67 | 3.67 |
| 465.58 | 5.12 | 5.12 |
| 530.68 | 3.46 | 3.46 |
| 481.60 | 2.67 | 2.67 |
| 485.60 | 4.95 | 4.95 |
| 556.72 | 4.16 | 4.16 |
| 465.60 | 3.70 | 3.70 |
| 464.60 | 5.08 | 5.08 |
| 555.73 | 3.96 | 3.96 |
| 506.66 | 3.17 | 3.17 |
| 497.65 | 6.04 | 6.04 |
| 555.73 | 4.13 | 4.13 |
| 484.61 | 5.13 | 5.13 |
| 451.56 | 4.73 | 4.73 |
| 455.56 | 1.97 | 1.97 |
| 498.64 | 5.44 | 5.44 |
| 480.62 | 2.47 | 2.47 |
| 498.64 | 5.44 | 5.44 |
| 490.64 | 5.62 | 5.62 |
| 458.57 | 5.02 | 5.02 |
| 581.77 | 4.66 | 4.66 |
| 490.66 | 4.20 | 4.20 |
| 480.62 | 2.47 | 2.47 |
| 482.64 | 5.62 | 5.62 |
| 480.62 | 2.64 | 2.64 |
| 563.50 | 6.32 | 6.32 |
| 480.62 | 2.47 | 2.47 |
| 464.62 | 3.67 | 3.67 |
| 483.62 | 5.74 | 5.74 |
| 458.57 | 3.95 | 3.95 |
| 490.66 | 4.20 | 4.20 |
| 474.64 | 5.49 | 5.49 |